1. Home
  2. ADBT vs NSPR Comparison

ADBT vs NSPR Comparison

Compare ADBT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advasa Holdings Inc. Common Stock

ADBT

Advasa Holdings Inc. Common Stock

N/A

Current Price

$0.08

Market Cap

39.9M

Sector

Technology

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

SELL

Current Price

$0.54

Market Cap

38.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ADBT
NSPR
Founded
2017
2005
Country
Japan
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
38.9M
IPO Year
2025
2009

Fundamental Metrics

Financial Performance
Metric
ADBT
NSPR
Price
$0.08
$0.54
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $2.67
AVG Volume (30 Days)
★ 3.8M
408.2K
Earning Date
11-20-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ 0.01
N/A
Revenue
N/A
★ $2,310,000.00
Revenue This Year
N/A
$9.38
Revenue Next Year
N/A
$67.09
P/E Ratio
$10.89
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.07
$0.43
52 Week High
$4.99
$2.17

Technical Indicators

Market Signals
Indicator
ADBT
NSPR
Relative Strength Index (RSI) 6.62 42.65
Support Level N/A $0.44
Resistance Level $0.13 $0.79
Average True Range (ATR) 0.01 0.13
MACD 0.03 -0.01
Stochastic Oscillator 19.53 19.41

Price Performance

Historical Comparison
ADBT
NSPR

About ADBT Advasa Holdings Inc. Common Stock

Advasa Holdings Inc is a financial technology and services company that offers a suite of financial services and solutions. Its earned wage access (EWA) service, named 'FUKUPE', provides employees with real-time access to their earned wages through cashless receipts and settlements that integrate seamlessly with wallets, cards, and bank accounts. The company also licenses its EWA technology portfolio and offers OEM (original equipment manufacturer) services. The company generates the majority of revenue from the provision of software maintenance services. Geographically, the company operates only in Japan.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: